HOX genes function in Breast Cancer development

SA de Bessa Garcia, M Araújo, T Pereira… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Breast cancer develops in the mammary glands during mammalian adulthood and is
considered the second most common type of human carcinoma and the most incident and …

Clinical utility of RASSF1A methylation in human malignancies

AM Grawenda, E O'neill - British journal of cancer, 2015 - nature.com
The high frequency of RASSF1A methylation has been noted in a vast number of patients in
a broad spectrum of malignancies, suggesting that RASSF1A inactivation is associated with …

Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas

M Kanai, JI Hamada, M Takada… - Oncology …, 2010 - spandidos-publications.com
HOX genes are known as master regulator genes which give cells positional information in
embryogenesis. In this study, we compared the expression patterns of 39 HOX genes …

[HTML][HTML] Epigenetically inactivated RASSF1A as a tumor biomarker

D Raos, M Ulamec, AK Bojanac… - Bosnian journal of …, 2021 - ncbi.nlm.nih.gov
RASSF1A, one of the eight isoforms of the RASSF1 gene, is a tumor suppressor gene that
influences tumor initiation and development. In cancer, RASSF1A is frequently inactivated …

BRCA1 promoter hypermethylation in Malignant breast tumors and in the histologically normal adjacent tissues to the tumors: exploring its potential as a biomarker …

Y Oubaddou, M Oukabli, S Fenniche, A Elktaibi… - Genes, 2023 - mdpi.com
The hypermethylation status of the promoter region of the breast cancer 1 (BRCA1), a well-
known tumor suppressor gene, has been extensively investigated in the last two decades as …

HOXA5-mediated stabilization of IκBα inhibits the NF-κB pathway and suppresses malignant transformation of breast epithelial cells

P Pai, G Wang, WW Teo, D Raez-Rodriguez… - Cancer research, 2022 - AACR
HOXA5 is a transcription factor and tumor suppressor that promotes differentiation of breast
epithelial cells and is frequently lost during malignant transformation. HOXA5 loss alone …

Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors

AHA Wahab, HA El-mezayen, H Sharad, SA Rahman - Tumor biology, 2011 - Springer
Hypermethylation at the promoter region is an important epigenetic mechanism underlying
the inactivation of tumor suppressor genes and frequently occurs as an early event in the …

Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients

G Sharma, S Mirza, YH Yang… - Analytical Cellular …, 2009 - content.iospress.com
Background: Methylation-mediated suppression of detoxification, DNA repair and tumor
suppressor genes has been implicated in cancer development. This study was designed to …

Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients

S Challouf, S Ziadi, R Zaghdoudi, F Ksiaa… - Clinica Chimica …, 2012 - Elsevier
BACKGROUND: Aberrant methylation in the promoter of tumor-related genes is associated
closely with epigenetically mediated gene silencing. The aim of the present study was to …

BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

A Bal, S Verma, K Joshi, A Singla, R Thakur, S Arora… - Virchows Archiv, 2012 - Springer
BRCA1 mutations have been associated with hereditary breast cancer only. Recent studies
indicate that a subgroup of sporadic breast cancer might also be associated with reduction …